stocks

Eli Lilly blows past estimates, hikes sales outlook as Zepbound and Mounjaro demand surge again

Eli Lilly reported that sales of obesity drug Zepbound and diabetes treatment Mounjaro surged again in the third quarter.

CNBC Stocks

Why is Glaukos stock surging today?

Investing.com

Adidas sees Europe rebound in fourth quarter, streaks ahead in China

Investing.com

Caterpillar tops quarterly profit view, but shares sink after unchanged annual growth forecast

Investing.com

Clorox appoints Unilever executive as its new CEO

Investing.com

Micron shares dip as Samsung’s post-earnings selloff spreads to memory peers

Investing.com

Premarket movers: Microsoft rises; Alphabet drags software stocks lower

Investing.com

Analyst explains why you should buy the pullback in Google shares

Investing.com

Shell and Total post highest quarterly profit since 2022

Investing.com

Why is Sprouts Farmers Market stock plunging today?

Investing.com

Alphabet stock sinks as search woes cause revenue miss, cash burn worsens

Investing.com

Merck tops quarterly estimates, hikes profit outlook as new Keytruda form shows strength

Merck's immunotherapy Keytruda, including a newer injectable form of the drug, showed stronger-than-expected sales.

CNBC Stocks

Restaurant Brands reports mixed results as Burger King's U.S. turnaround shows signs of success

Burger King's U.S. restaurants outperformed, while Popeyes disappointed.

CNBC Stocks

Samsung Electronics shares slid despite record profit in the third-quarter

Samsung Electronics reported third-quarter earnings on Thursday.

CNBC Stocks

Why is Hitachi stock plunging today?

Investing.com

Hitachi shares slide as Q2 profit drop overshadows strong top-line earnings

Investing.com

Advantest shares jump as AI chip demand drives earnings outlook upgrade

Investing.com

BOK board member flags won volatility despite AI chip export boom - RTRS

Investing.com